Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

The best bed sheets are comfortable and soft. We've tested a range from cotton percale to linen. Our favorites include ...

Arvinas Inc. (NASDAQ:ARVN), a biotechnology company specializing in protein degradation therapeutics, stands at a critical juncture as it approaches the release of pivotal clinical trial data.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

The CNN defamation trial with U.S. Navy veteran Zachary Young revealed a rare inside look at the network’s books that showed ...

NEW YORK, NY / ACCESS Newswire / January 26, 2025 / Rosen Law Firm PAWHY: Rosen Law Firm, a global investor rights law firm, announces an ...

He said in a perfect world he would have seen CNN’s balance sheets and income statements, but those were "never provided." Instead, CNN provided 1120 U.S. Corporate Income Tax returns for the ...

John Marshall Bancorp, Inc. (Nasdaq: JMSB) (the "Company"), parent company of John Marshall Bank (the "Bank"), reported net income of $4.8 million ($0.33 per diluted common share) for the quarter ...

MSNBC is getting spun out, CNN is restructuring and the Murdochs are launching a streamer. But can any of them survive the ...

Sana is a gene and cell therapy clinical-stage biotech firm and a penny stock that has fallen by 48.5% in the year leading to January 17, 2025. What may set this company apart from a host of similar ...